Comparative evaluation of the effects of adjuvant clonidine to bupivacine with solo bupivacine for axillary brachial plexus block
Keywords:
Axillary brachial plexus, clonidine, bupivacine, duration of analgesia.Abstract
Background: Peripheral nerve blockade has become an important and growing part of anesthesia. It offers an excellent substitute for patients
who are hemodynamically compromised or too ill to tolerate general anesthesia. However, there is no data available on the effect of clonidine
with bupivacaine in axillary plexus block or any peripheral nerve block.Aim: Therefore, present study was designed to compare the effects of
adjuvant clonidine to bupivacine with solo bupivacine for axillary brachial plexus block. Materials and Methods: The present prospective,
randomized, controlled, study was conducted in the Department of Anaesthesiology and Intensive Care. Patients were arbitrarily assigned to one
of the two groups of 30 patients each. Group I (n=30) Patients received 25 ml of Bupivacaine (0.5%) + 1 ml of normal saline. Whereas, Group II
(n =30) Patients received 25 ml of Bupivacaine (0.5%) + 1ml (150μg) clonidine. Results: It is evident that onset of motor block was 8.72 minute
faster in group I Bupivacaine clonidine patients. Duration of motor block was significantly high in Bupivacaine clonidine group patients
(440.4±42.18 min) compare to Bupivacaine group patients (198.33±27.86 min) with p value <0.01. Duration of analgesic effects was
significantly high in bupivacaine clonidine patients in comparison of bupivacaine patients (718.6±40.6 min vs 512.8 ± 32.9 min, p<0.01).
Conclusion: Findings of the current study suggest that use of clonidine as adjuvant to bupivacaine hasten motor and sensory block as well as
prolonged duration of analgesic effects in comparison of solo use of bupivacaine without inducing any side effects except some sedation in
postoperative period.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2021 Shrutika Bhagat, Madiha Shadab, Shreya Saurav, Binod Kashyap

This work is licensed under a Creative Commons Attribution 4.0 International License.